Literature DB >> 5462147

Ultrastructural studies of the passage of gold thiomalate across the renal glomerular capillary wall.

S W Strunk, M Ziff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5462147     DOI: 10.1002/art.1780130105

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  8 in total

Review 1.  Contributions of renal biopsy studies to the understanding of disease.

Authors:  A E Seymour; B H Spargo; R Penksa
Journal:  Am J Pathol       Date:  1971-12       Impact factor: 4.307

2.  The natural course of gold nephropathy: long term study of 21 patients.

Authors:  C L Hall; N J Fothergill; M M Blackwell; P R Harrison; J C MacKenzie; A G MacIver
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-26

3.  Gold induced nephropathy in rheumatoid arthritis and HLA class II genes.

Authors:  L I Sakkas; I C Chikanza; R W Vaughan; K I Welsh; G S Panayi
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

4.  Effect of two gold compounds on lysosomes.

Authors:  P M Graabaek; S M Pedersen
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

5.  Gold-induced immune complex nephritis in seronegative rheumatoid arthritis.

Authors:  B V Skrifvars; T S Törnroth; G N Tallqvist
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

6.  Glomerulonephritis with - and 1C-globulin deposits induced in rats by mercuric chloride.

Authors:  J Bariety; P Druet; F Laliberte; C Sapin
Journal:  Am J Pathol       Date:  1971-11       Impact factor: 4.307

7.  Evaluation of the renal injury from gold salts and nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis.

Authors:  N Giordano; E Frati; A Fioravanti; A Taddeo; G Morozzi; R Marcolongo
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

8.  The role of hypersensitivity and the immune response in influencing susceptibility to metal toxicity.

Authors:  G Kazantzis
Journal:  Environ Health Perspect       Date:  1978-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.